Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura

Title
Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura
Authors
Keywords
-
Journal
Drug Design Development and Therapy
Volume Volume 13, Issue -, Pages 1251-1258
Publisher
Dove Medical Press Ltd.
Online
2019-04-17
DOI
10.2147/dddt.s134470

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now